ProCE Banner Activity

Expert Insights on Advances in Immune Thrombocytopenia

Podcast Episodes
Listen to Keith McCrae, MD, Nichola Cooper, MD, and Rachael Grace, MD, MMSc, provide expert insights on ITP management and address frequently asked questions from a live CCO symposium at ASH 2021 on new and emerging therapeutic options, including special patient populations.

Released: February 07, 2022

Expiration: February 06, 2023

Share

Faculty

Rachael Grace

Rachael Grace, MD, MMSc

Assistant Professor of Pediatrics
Harvard Medical School
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, Massachusetts, USA

Keith R. McCrae

Keith R. McCrae, MD

Professor, Medicine/Hematology/Oncology
Case Western Reserve University School of Medicine
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Dova Pharmaceuticals

Sanofi Genzyme

Faculty Disclosure

Primary Author

Rachael Grace, MD, MMSc

Assistant Professor of Pediatrics
Harvard Medical School
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Boston, Massachusetts, USA

Rachael Grace, MD, MMSc, has disclosed that she has received funds for research support from Agios, Dova Pharmaceuticals, and Novartis and consulting fees from Principia.

Keith R. McCrae, MD

Professor, Medicine/Hematology/Oncology
Case Western Reserve University School of Medicine
Cleveland, Ohio

Keith R. McCrae, MD, has disclosed that he has received consulting fees from Dova Pharmaceuticals, Novartis, Rigel Pharmaceuticals, and Sanofi Genzyme.